These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8854812

  • 21. Palliative treatment of hepatocellular carcinoma with percutaneous ethanol injection using tumor's feeding artery occlusion under the ultrasonic color Doppler guidance.
    Rustemović N, Vucelić B, Opacić M, Ostojić R, Pulanić R, Petrovecki M, Radanović B, Marinić J, Pulanić D.
    Coll Antropol; 2004 Dec; 28(2):781-91. PubMed ID: 15666612
    [Abstract] [Full Text] [Related]

  • 22. [Diagnosis and treatment for recurrent hepatocellular carcinoma].
    Yoshikawa M, Ebara M, Fukuda H, Sugiura N, Saisho H.
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):327-32. PubMed ID: 9492824
    [Abstract] [Full Text] [Related]

  • 23. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK, Wikström M, Flechtenmacher C, Filser T, Dueber C.
    Cardiovasc Intervent Radiol; 2006 Feb; 29(5):778-84. PubMed ID: 16779690
    [Abstract] [Full Text] [Related]

  • 24. Combination of transcatheter arterial embolization and percutaneous ethanol injection for hepatocellular carcinoma: comparison of efficacies of doxorubicin and epirubicin in transcatheter arterial embolization.
    Nakamura S, Tanaka K.
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-46-S6-49. PubMed ID: 9151916
    [Abstract] [Full Text] [Related]

  • 25. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K, Shirahama M, Shigematsu H, Miyamoto Y, Torii Y, Irie K, Ishibashi H.
    Hepatogastroenterology; 2001 Apr; 48(41):1409-15. PubMed ID: 11677976
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of combined therapy with chemoembolization and ethanol injection for advanced hepatocellular carcinoma.
    Yamamoto K, Masuzawa M, Kato M, Kurosawa K, Kaneko A, Ishida H, Imamura E, Park NJ, Shirai Y, Fujimoto K, Michida T, Hayashi N, Ikeda M.
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-50-S6-55. PubMed ID: 9151917
    [Abstract] [Full Text] [Related]

  • 27. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
    Jin-no K.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
    [Abstract] [Full Text] [Related]

  • 28. Non-invasive loco-regional therapy for hepatocellular carcinoma.
    Tanikawa K.
    Semin Surg Oncol; 1996 Feb; 12(3):189-92. PubMed ID: 8727609
    [Abstract] [Full Text] [Related]

  • 29. [A case of hepatocellular carcinoma implantation to chest wall by percutaneous ethanol injection therapy].
    Nakano H, Sasaki Y, Imaoka S, Furukawa H, Ishikawa O, Kabuto T, Kameyama M, Ohigashi H, Hiratsuka M, Nakamori S.
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2350-3. PubMed ID: 7944477
    [Abstract] [Full Text] [Related]

  • 30. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.
    Ohnishi K.
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1254-8. PubMed ID: 9730384
    [Abstract] [Full Text] [Related]

  • 31. Successful laparoscopic radiofrequency ablation of hepatocellular carcinoma adhered to the mesentery after transcatheter arterial embolization.
    Kurokohchi K, Masaki T, Himoto T, Deguchi A, Nakai S, Yoneyama H, Yoshida S, Kimura Y, Inoue H, Kinekawa F, Yoshitake A, Izuishi K, Watanabe S, Kuriyama S.
    Oncol Rep; 2005 Jan; 13(1):65-8. PubMed ID: 15583803
    [Abstract] [Full Text] [Related]

  • 32. Liver atrophy after transcatheter arterial embolization and percutaneous ethanol injection therapy for a minute hepatocellular carcinoma.
    Motoo Y, Okai T, Matsui O, Ohta H, Sawabu N.
    Gastrointest Radiol; 1991 Jan; 16(2):164-6. PubMed ID: 1849852
    [Abstract] [Full Text] [Related]

  • 33. [Hepatocellular carcinoma recurrence in PEI site--a case report].
    Ota H, Nagano H, Sakon M, Inoue T, Hayashi S, Kondo M, Arai I, Morimoto O, Yamamoto T, Nakamura M, Dono K, Umeshita K, Nakamori S, Wakasa K, Monden M.
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2421-4. PubMed ID: 12484090
    [Abstract] [Full Text] [Related]

  • 34. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions.
    Wakabayashi H, Ushiyama T, Ishimura K, Izuishi K, Karasawa Y, Masaki T, Watanabe S, Kuriyama S, Maeta H.
    J Surg Oncol; 2003 Feb; 82(2):98-103. PubMed ID: 12561065
    [Abstract] [Full Text] [Related]

  • 35. [Transcatheter arterial chemo-embolization combined with CT-guided percutaneous intratumoral injection of lipiodol-ethanol for the treatment of primary hepatocellular carcinoma].
    Wu P, Li L, Zhang Y.
    Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):391-3. PubMed ID: 10921042
    [Abstract] [Full Text] [Related]

  • 36. Laparoscopic ethanol injection therapy for hepatocellular carcinoma.
    Okano H, Shiraki K, Inoue H, Yamanaka T, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Murata K, Nakano T.
    Int J Oncol; 2002 Feb; 20(2):267-71. PubMed ID: 11788887
    [Abstract] [Full Text] [Related]

  • 37. [Multidisciplinary treatment for hepatocellular carcinoma invading the stomach].
    Takahashi M, Beppu T, Doi K, Ishiko T, Kai K, Doi Y, Okabe H, Egami H, Ashihara H, Fujiyama S, Ogawa M.
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1741-4. PubMed ID: 14619508
    [Abstract] [Full Text] [Related]

  • 38. Nonresectional therapies for hepatocellular carcinoma.
    Liu CL, Fan ST.
    Am J Surg; 1997 Apr; 173(4):358-65. PubMed ID: 9136797
    [Abstract] [Full Text] [Related]

  • 39. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
    Hasegawa I, Hirashima N.
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
    [Abstract] [Full Text] [Related]

  • 40. Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI.
    Arata S, Tanaka K, Okazaki H, Kondo M, Morimoto M, Saito S, Numata K, Nakamura S, Sekihara H.
    Hepatogastroenterology; 2001 Feb; 48(38):480-5. PubMed ID: 11379338
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.